BVT Call 115 6MK 20.09.2024/ DE000VM7N412 /

2024-05-24 8:44:16 AM	Chg.+0.02	Bid9:59:36 PM	Ask9:59:36 PM	Underlying	Strike price	Expiration date	Option type
1.73EUR	+1.17%	- Bid Size: -	- Ask Size: -	MERCK CO. D...	115.00 -	2024-09-20	Call

GlobeNewswire 05-07 CytomX Therapeutics Announces Clinical Collaboration with Merck to Evaluate CX-801 in Combination wi...

GlobeNewswire 05-06 Press Release Biocartis NV: Biocartis and Merck to Collaborate on Improving Patient Access to Person...

GlobeNewswire 05-02 Cerevance Achieves First Milestone in Research Collaboration with Merck

TeleTrader 04-25 Merck's Q1 sales rise by 9% to $15.8 billion

GlobeNewswire 04-02 Vaccinex Reports 2023 Financial Results and Provides Corporate Update

GlobeNewswire 03-06 IO Biotech Announces Acceptance of Abstract to be Presented at the 2024 American Association for Can...

GlobeNewswire 03-04 C4 Therapeutics Announces Strategic Discovery Research Collaboration with Merck KGaA, Darmstadt, Ger...

TeleTrader 02-02 Merck Group to expand investment in South Korea

TeleTrader 02-01 Merck's Q4 sales up 6% to $14.6B

TeleTrader 01-27 J&J, Merck CEOs to testify before Senate on drug prices

GlobeNewswire 01-23 Unnatural Products, Inc. Enters Research Collaboration with Merck

GlobeNewswire 2023-12-21 Arch Biopartners Receives Approval from Ethics Committee in Turkey to Proceed with Phase II Cardiac ...

GlobeNewswire 2023-12-19 Unnatural Products, Inc. Announces $32 Million in Series A Funding Led by Merck Global Health Innova...

GlobeNewswire 2023-12-14 ITM Executes License Agreement to Obtain Worldwide Exclusive License for the Clinical Development an...

GlobeNewswire 2023-12-12 C4 Therapeutics Announces License and Research Collaboration with Merck to Discover and Develop Degr...

GlobeNewswire 2023-12-05 HiberCell, Inc. Announces Clinical Collaboration with Merck to Evaluate HC-7366, an Activator of ISR...

GlobeNewswire 2023-12-04 Nasdaq Grants Vaccinex Extension Until March 4, 2024 to Regain Compliance with Listing Rule

GlobeNewswire 2023-11-13 Vaccinex Reports Third Quarter 2023 Financial Results and Provides Corporate Update

TeleTrader 2023-10-26 Merck's Q3 sales up 7% to $16B

TeleTrader 2023-10-20 Daiichi Sankyo, Merck announce collaboration on cancer drugs

GlobeNewswire 2023-10-17 ImmunOs Therapeutics Announces Clinical Trial Collaboration with Merck & Co., Inc., Rahway, NJ, USA

GlobeNewswire 2023-09-28 Merck KGaA, Darmstadt, Germany and Quris-AI Expand Collaboration

GlobeNewswire 2023-09-26 Vaccinex Reports Groundbreaking Findings at Medical Conferences Supporting Development of Pepinemab ...

TeleTrader 2023-08-29 US gov't reveals drugs subject to Medicare price debate

TeleTrader 2023-08-01 Merck posts Q2 sales of $15B, rising 3%